Cargando…
Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases
For over a half-century the anti-malarial drug chloroquine (CQ) has been used as a therapeutic agent, alone or in combination, to treat autoimmune diseases. However, neither the underlying mechanism(s) of action nor their molecular target(s) are well defined. The orphan nuclear receptor Nurr1 (also...
Autores principales: | Park, Tae-Yoon, Jang, Yongwoo, Kim, Woori, Shin, Joon, Toh, Hui Ting, Kim, Chun-Hyung, Yoon, Ho Sup, Leblanc, Pierre, Kim, Kwang-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820774/ https://www.ncbi.nlm.nih.gov/pubmed/31664129 http://dx.doi.org/10.1038/s41598-019-52085-w |
Ejemplares similares
-
Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1
por: Jang, Yongwoo, et al.
Publicado: (2021) -
Nurr1 (NR4A2) regulates Alzheimer’s disease‐related pathogenesis and cognitive function in the 5XFAD mouse model
por: Moon, Minho, et al.
Publicado: (2018) -
An optimized Nurr1 agonist provides disease-modifying effects in Parkinson’s disease models
por: Kim, Woori, et al.
Publicado: (2023) -
Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease
por: Kim, Ji-Won, et al.
Publicado: (2022) -
Clinical Approach to Autoimmune Epilepsy
por: Jang, Yoonhyuk, et al.
Publicado: (2020)